A study of impact of low dose albumin infusion on outcome in patients with cirrhosis and sepsis
Phase 2
- Conditions
- Health Condition 1: K746- Other and unspecified cirrhosis ofliver
- Registration Number
- CTRI/2020/03/023794
- Lead Sponsor
- Kalinga Institute Of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
Patients giving informed consent
>18 years
All etiologies of cirrhosis with Sepsis
Exclusion Criteria
Patients with mean arterial pressure <65mm of Hg
Congestive heart failure with ejection fraction <50%
Hepatocellular carcinoma
Chronic kidney disease with Serum creatinine >2mg/dl
Mechanical ventilation at inclusion time
Refusal to participate
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method In hospital mortality.Timepoint: Time of discharge/ Death
- Secondary Outcome Measures
Name Time Method Mortality at day 30, Improvement in sepsis and morbidity. <br/ ><br>Examples-hypotension, pneumonia, serum creatine, INR, sensorium, <br/ ><br>serum bilirubin. <br/ ><br>Timepoint: Mortality at day 30